ORGO (Organogenesis Holdings) Other Long Term Assets: $22.9 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ORGO Organogenesis Holdings Inc ORGO
62 GF Score
Price $1.79
GF Value $3.05
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Organogenesis Holdings Other Long Term Assets?

Organogenesis Holdings ORGO -1.91% 62 Other Long Term Assets is $22.9 Mil as of Jun. 2026. GuruFocus rates ORGO with a GF Score™ of 62/100 and a GF Value™ of $3.05 (Possible Value Trap). The stock has 6 warning signs investors should review.

Organogenesis Holdings's other long-term assets for the quarter that ended in Jun. 2026 was $22.9 Mil.

Organogenesis Holdings's quarterly other long-term assets increased from Dec. 2025 ($39.2 Mil) to Mar. 2026 ($61.5 Mil) but then stayed the same from Mar. 2026 ($61.5 Mil) to Jun. 2026 ($22.9 Mil).

Organogenesis Holdings's annual other long-term assets increased from Dec. 2023 ($34.0 Mil) to Dec. 2024 ($44.5 Mil) but then declined from Dec. 2024 ($44.5 Mil) to Dec. 2025 ($39.2 Mil).

Organogenesis Holdings Other Long Term Assets Historical Data

* Premium members only.

The historical data trend for Organogenesis Holdings's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Organogenesis Holdings Other Long Term Assets Chart

Organogenesis Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.53 31.53 33.99 44.47 39.17

Organogenesis Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.48 60.00 39.17 61.46 22.93
ORGO
62GF Score
Organogenesis Holdings Inc ORGO
Other Long Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Organogenesis Holdings Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Frequently Asked Questions Learn more about Other Long Term Assets →
What does a Other Long Term Assets of $22.9 Mil mean?
Organogenesis Holdings (ORGO) has a Other Long Term Assets of $22.9 Mil as of Jun. 2026. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Organogenesis Holdings and its competitors.
Is Organogenesis Holdings' Other Long Term Assets too high?
Organogenesis Holdings' current Other Long Term Assets is $22.9 Mil. Overall, Organogenesis Holdings has a GF Score™ of 62/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Organogenesis Holdings' Other Long Term Assets compare to AKBA and TKNO?
Organogenesis Holdings' Other Long Term Assets of $22.9 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Drug Manufacturers company?
A good Other Long Term Assets depends on the Drug Manufacturers industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Organogenesis Holdings and its competitors. Organogenesis Holdings's current Other Long Term Assets is $22.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Organogenesis Holdings stock overvalued right now?
Based on GuruFocus' analysis, Organogenesis Holdings (ORGO) is currently considered Possible Value Trap. The stock's GF Value™ is $3.05, compared to a current price of $1.79 — trading 41.3% below its estimated fair value. The current Other Long Term Assets is $22.9 Mil. Organogenesis Holdings' overall GF Score™ is 62/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For Organogenesis Holdings (ORGO), the current Other Long Term Assets is $22.9 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Organogenesis Holdings (ORGO) Overvalued in 2026?

Based on GuruFocus' analysis, Organogenesis Holdings stock appears to be undervalued. The current stock price of $1.79 is trading 41.3% below its estimated GF Value™ of $3.05. GuruFocus considers Organogenesis Holdings to be Possible Value Trap.

Key valuation signals for ORGO:

  • Other Long Term Assets: $22.9 Mil
  • GF Value™: $3.05 vs. price of $1.79 (41.3% below fair value)
  • GF Score™: 62/100 with 6 warning signs

No single metric tells the full story. See the ORGO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Organogenesis Holdings Business Description

Other Exchanges 2PQ:Germany
Address 85 Dan Road, Canton, MA, USA, 02021
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
62GF Score

Get the complete analysis for ORGO

Other Long Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.79
Price
$3.05
GF Value